Status of neonatal screening for spinal muscular atrophy in Europe
  • All newborns are screened for SMA under national programme
  • SMA has been added to national programme, screening to start shortly
  • SMA is being reviewed for national neonatal screening programme
  • Situation varies – hover over map for more detail
  • No SMA screening / no data available
  • Ongoing academic pilot study
  • Past academic pilot study
Status of neonatal screening for spinal muscular atrophy in Europe

Progress of newborn screening for SMA in Europe

Percentage of newborns being routinely screened for SMA in Europe as of 1 March 2024

WIDER EUROPE (includes all of Russia, all of Turkey, and South Caucasus): 71%
GEOGRAPHICAL EUROPE: 65%
EUROPEAN UNION: 64%

Screening for SMA outside of Europe

The following countries and territories screen all newborns for spinal muscular atrophy:

  • Australia: SMA is included in newborn screening programmes (routine or pilot) in a number of provinces.
  • Canada: Approx. 72% of newborns are screened for SMA. The disorder is included in routine screening programmes in the following provinces: Alberta, British Columbia, Manitoba, Ontario and Saskatchewan, as well as in Nunavut and the Northwest Territories.
  • Japan: Province-level pilot projects in place.
  • Qatar: All newborns are screened for SMA since approx. 2021.
  • Taiwan: A pilot project in place during 2014–2016 followed by routine screening of all newborns.
  • United States: 100% of newborns are screened for SMA. The disorder was included in the federal Uniform Recommended Screening Panel in 2019 and gradually rolled out to all the 50 states by early 2024.